Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma

BACKGROUND: Ovarian carcinoma is highly dependent on the ubiquitin proteasome system (UPS), but its clinical response to treatment with the proteasome inhibitor bortezomib has been disappointing. This has driven exploration of alternate approaches to target the UPS in ovarian cancer. Recently, prote...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Ovarian Res
Autores principales: Jiang, Rosie T., Yemelyanova, Anna, Xing, Deyin, Anchoori, Ravi K., Hamazaki, Jun, Murata, Shigeo, Seidman, Jeffrey D., Wang, Tian-Li, Roden, Richard B. S.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5547474/
https://ncbi.nlm.nih.gov/pubmed/28784174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-017-0347-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares